CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 227 enrolled
Drug / intervention
Crystallized phenol treatmentprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04423510
NCT04423510N/ACompleted

Previously Operated Recurrent Pilonidal Sinus Treated With Crystallized Phenol: Twenty Years Experience

Osman DOĞRU·observational·Posted Jun 9, 2020·Updated Jun 9, 2020

In Brief

An observational study evaluating Crystallized phenol treatment for Pilonidal Sinus. Completed, enrolled 227 participants.

Detailed Summary

Postoperative recurrent pilonidal sinus disease is troublesome and its treatment is challenge. Many treatment modalities have been advocated in the treatment of recurrent pilonidal sinus disease; however, there is still no consensus in the literature. Some minimally invasive techniques are used alone or as an adjunct to surgery. Crystallized phenol is the most popular method in the nonoperative treatment of primer pilonidal sinus disease. But its long term effect in the postoperative recurrent cases is unclear. Investigators aimed to present the long-term efficacy of crystallized phenol treatment on postoperative recurrent pilonidal sinus disease through our results collected within the last 20 years.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPilonidal Sinus
Countries--
Collaborators--

Timeline

N/ACompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 9, 2020
Enrollment StartMar 1, 1995
Primary CompletionFeb 1, 2015
Study CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 19.9 yearsPosted 6.1 years ago

Interventions

Crystallized phenol treatmentprocedure